Trasylol cited in two lawsuits
Posted by Administrator (admin) on Oct 13 2008 at 4:52 PM
Trasylol >>

A lawsuit has been filed in Illinois St. Clair County Circuit Court on behalf of two heart surgery patients who received Trasylol injection before their operations to control bleeding. Both the plaintiffs claim that the drug resulted in their kidney failure and eventually in the death of one of patient. The plaintiffs are seeking damages for acute renal failure, requiring dialysis treatment. The suit was filed on September 25, 2008.

One of the plaintiffs received a Trasylol injection in August 1996. The second plaintiff received it in 2005.

Trasylol (generically known as Aprotinin) is an injectable anti-bleeding medication manufactured by Bayer. It was removed from the market in November 2007. Before 2007, it was extensively used to control bleeding during cardiac bypass surgery to reduce the need for transfusions.

Trasylol started raising concerns about adverse effects in 2006, when the drug was associated to an increased risk of death and kidney failure. In December 2006, warnings about Trasylol kidney failure were added to the label of the drug.

Several people who receive Trasylol are not aware that they were given the drug prior to the heart surgery. The initial symptoms of problems generally involve an instant requirement for dialysis treatment due to kidney failure. Dialysis does the same action as normal kidneys by removing waste products from the blood and using ultrafiltration to remove excess fluid as urine.

Comments